Trevi Therapeutics appoints David Hastings as chief financial officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Trevi Therapeutics appoints David Hastings as chief financial officer
(NASDAQ: TRVI) Delayed: 14.41 -0.26 (1.77%)
Previous Close $14.67    52 Week High $ 
Open $14.68    52 Week Low $ 
Day High $14.75    P/E N/A 
Day Low $14.33    EPS $ 
Volume 1,364,965